Compliance of smokeless tobacco supply chain actors and products with tobacco control laws in Bangladesh, India and Pakistan: protocol for a multicentre sequential mixed-methods study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 06 2020
Historique:
entrez: 20 6 2020
pubmed: 20 6 2020
medline: 16 2 2021
Statut: epublish

Résumé

South Asia is home to more than 300 million smokeless tobacco (ST) users. Bangladesh, India and Pakistan as signatories to the Framework Convention for Tobacco Control (FCTC) have developed policies aimed at curbing the use of tobacco. The objective of this study is to assess the compliance of ST point-of-sale (POS) vendors and the supply chain with the articles of the FCTC and specifically with national tobacco control laws. We also aim to assess disparities in compliance with tobacco control laws between ST and smoked tobacco products. The study will be carried out at two sites each in Bangladesh, India and Pakistan. We will conduct a sequential mixed-methods study with five components: (1) mapping of ST POS, (2) analyses of ST samples packaging, (3) observation, (4) survey interviews of POS and (5) in-depth interviews with wholesale dealers/suppliers/manufacturers of ST. We aim to conduct at least 300 POS survey interviews and observations, and 6-10 in-depth interviews in each of the three countries. Data collection will be done by trained data collectors. The main statistical analysis will report the frequencies and proportions of shops that comply with the FCTC and local tobacco control policies, and provide a 95% CI of these estimates. The qualitative in-depth interview data will be analysed using the framework approach. The findings will be connected, each component informing the focus and/or design of the next component. Ethical approvals for the study have been received from the Health Sciences Research Governance Committee at the University of York, UK. In-country approvals were taken from the National Bioethics Committee in Pakistan, the Bangladesh Medical Research Council and the Indian Medical Research Council. Our results will be disseminated via scientific conferences, peer-reviewed research publications and press releases.

Identifiants

pubmed: 32554728
pii: bmjopen-2019-036468
doi: 10.1136/bmjopen-2019-036468
pmc: PMC7304837
doi:

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e036468

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMC Med. 2015 Aug 17;13:194
pubmed: 26278072
BMC Med Res Methodol. 2013 Sep 18;13:117
pubmed: 24047204
JMIR Public Health Surveill. 2015 Aug 12;1(2):e8
pubmed: 27227142
Tob Control. 2019 May;28(Suppl 1):s31-s36
pubmed: 29794232
Tob Control. 2019 Jun;28(Suppl 2):s119-s128
pubmed: 29880598
IARC Monogr Eval Carcinog Risks Hum. 2007;89:1-592
pubmed: 18335640
Indian J Cancer. 2013 Jul-Sep;50(3):245-9
pubmed: 24061466
Lancet Oncol. 2008 Jul;9(7):667-75
pubmed: 18598931
Int J Cancer. 2016 Mar 15;138(6):1368-79
pubmed: 26443187
Int J Cancer. 2014 Sep 15;135(6):1433-43
pubmed: 24302487
PLoS One. 2017 Jul 10;12(7):e0180445
pubmed: 28692704
Respirology. 2003 Dec;8(4):419-31
pubmed: 14708551
Tob Control. 2019 Jun;28(Suppl 2):s104-s112
pubmed: 30065075
Prev Med. 2016 Dec;93:128-134
pubmed: 27713100
BMJ. 2003 Jul 19;327(7407):154-7
pubmed: 12869461
Tob Control. 2011 May;20(3):e2
pubmed: 21109685
Tob Induc Dis. 2019 May 25;17:45
pubmed: 31516488
Prev Chronic Dis. 2016 Feb 18;13:E25
pubmed: 26890408
Nicotine Tob Res. 2017 Dec 13;20(1):12-21
pubmed: 27928050
Nicotine Tob Res. 2019 Jan 1;21(1):95-100
pubmed: 29281083
Tob Induc Dis. 2016 Nov 21;14:36
pubmed: 27895546
Tob Control. 2020 Mar;29(2):241-242
pubmed: 30696785
Tob Control. 2018 Jan 13;:
pubmed: 29332006
Tob Control. 2019 May;28(3):261-267
pubmed: 29895704
Tob Control. 2016 Oct;25(Suppl 1):i67-i74
pubmed: 27697950
Nicotine Tob Res. 2016 Apr;18(4):424-30
pubmed: 25795659

Auteurs

Zohaib Khan (Z)

Office of Research, Innovation, and Commercialization, Khyber Medical University, Peshawar, Pakistan.
Institute of Public Health and Social Sciences, Khyber Medical University, Peshawar, Pakistan.

Rumana Huque (R)

Department of Economics, University of Dhaka, Dhaka, Bangladesh.
Department of Research and Development, ARK Foundation, Dhaka, Bangladesh.

Aziz Sheikh (A)

Division of Community Health Sciences, University of Edinburgh, Edinburgh, UK.

Anne Readshaw (A)

Department of Health Sciences, University of York, York, UK anne.readshaw@york.ac.uk.

Jappe Eckhardt (J)

Department of Politics, University of York, York, UK.

Cath Jackson (C)

Department of Health Sciences, University of York, York, UK.
Vaild Research Ltd, Wetherby, UK.

Mona Kanaan (M)

Department of Health Sciences, University of York, York, UK.

Romaina Iqbal (R)

Department of Community Health Sciences and Medicine, Aga Khan University, Karachi, Pakistan.

Zohaib Akhter (Z)

Department of Community Health Sciences and Medicine, Aga Khan University, Karachi, Pakistan.

Suneela Garg (S)

Department of Community Medicine, Maulana Azad Medical College, New Delhi, Delhi, India.

Mongjam Meghachandra Singh (MM)

Department of Community Medicine, Maulana Azad Medical College, New Delhi, Delhi, India.

Fayaz Ahmad (F)

Institute of Public Health and Social Sciences, Khyber Medical University, Peshawar, Pakistan.

S M Abdullah (SM)

Department of Economics, University of Dhaka, Dhaka, Bangladesh.
Department of Research and Development, ARK Foundation, Dhaka, Bangladesh.

Arshad Javaid (A)

Office of Research, Innovation, and Commercialization, Khyber Medical University, Peshawar, Pakistan.

Javaid A Khan (J)

Department of Pulmonary medicine, Aga Khan University, Karachi, Pakistan.

Lu Han (L)

Department of Health Sciences, University of York, York, UK.

Aziz Rahman (A)

Faculty of Health, Federation University Australia, Ballarat, Victoria, Australia.

Kamran Siddiqi (K)

Department of Health Sciences, University of York, York, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH